Molecular forms of serum pancreatic stone protein in acute pancreatitis

International Journal of Pancreatology

Volumn 25, Issue 1, 1999, Pages 17-21

  Nakae, Yasuyuki ^a   Naruse, Satoru ^a   Kitagawa, Motoji ^a   Ishiguro, Hiroshi ^a   Kato, Masanori ^b   Hayakawa, Shinobu ^b   Kondo, Takaharu ^a   Hayakawa, Tetsuo ^a  

^a NAGOYA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b Maruko Pharmaceutical Co Ltd   (Japan)

Author keywords

Acute pancreatitis; Molecular form; Pancreatic stone protein; Trypsin

Indexed keywords

LITHOSTATHINE; TRYPSIN;

ACUTE PANCREATITIS; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; EARLY DIAGNOSIS; ENZYME IMMUNOASSAY; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN DETERMINATION;

EID: 0032945455     PISSN: 01694197     EISSN: None     Source Type: Journal    
DOI: 10.1385/ijgc:25:1:17     Document Type: Article

References (23)

1. 1 Creuzfeldt W, Schmidt H. Aetiology and pathogenesis of pancreatitis (current concept). Scand J Gastroenterol Suppl 1970; 6: 47-62.
2. 2 Nakae Y, Naruse S, Kitagawa M, Hirao S, Yamamoto R, Hayakawa T. Activation of trypsinogen in experimental models of acute pancreatitis in rats. Pancreas 1995; 10: 306-313.
3. 3 Rinderknecht H. Activation of pancreatic zymogens. Dig Dis Sci 1986; 31: 314-321.
4. 4 Steer ML, Meldolesi J. Pathogenesis of acute pancreatitis. Annu Rev Med 1988; 39: 95-105.
5. 5 Ohlsson K, Ganrot PO, Laurell CB. In vivo interaction between trypsin and some plasma proteins in relation to tolerance to intravenous infusion of trypsin in dog. Acta Chir Scand 1971; 137: 113-121.
6. 6 Brodrick JW, Geokas MC, Largman C, Fassett M, Johnson JH. Molecular forms of immunoreactive pancreatic cationic trypsin in pancreatitis patients sera. Am J Physiol 1979; 237: E478-480.
7. 7 Gudgeon AM, Heath DI, Hurley P, Jahanli A, Patel G, Wilson C, et al. Trypsinogen activation peptides assay in the early prediction of severity of acute pancreatitis. Lancet 1990; 335: 4-8.
8. 8 Karanjia ND, Widdison AL, Jehanli A, Hermon-Taylor J, Reber HA. Assay of trypsinogen activation in the cat experimental models of acute pancreatitis. Pancreas 1993; 8: 189-195.
9. 2 macroglobulin-protease complexes in severe and mild attacks. Gut 1991; 32: 430-434.
10. 10 Nakae Y, Hayakawa T, Kondo T, Shibata T, Kitagawa M, Sakai Y, et al. Diagnostic value of serum α2-macroglobulin-trypsin complex in pancreatic diseases using a colorimetric assay with a synthetic chromogenic substrate. Jpn J Gastroenterol 1991; 88: 2853-2860.
11. 11 Sobajima H, Hayakawa T, Kondo T, Shibata T, Kitagawa M, Sakai Y, et al. Monitoring serum tryptic activity and effect of trypsin inhibitor on rat acute pancreatitis. Digestion 1994; 55: 90-96.
12. 12 Nakae Y, Hayakawa T, Kondo T, Shibata T, Kitagawa M, Sakai Y, et al. Serum α2-macroglobulin-trypsin complex and early recognition of severe acute pancreatitis after endoscopic retrograde pancreatography. J Gastroenterol Hepatol 1994; 9: 272-276.
13. 13 Hedström J, Sainio V, Kemppainen E, Haapianen R, Kivilaakso E, Schröder T, et al. Serum complex of trypsin 2 and al antitrypsin as diagnostic and prognostic marker of acute pancreatitis: clinical study in consecutive patients. Br Med S 1996; 313: 333-337.
14. 14 Multigner L, De Caro A, Lombardo D, Campese D, Sahles H. Pancreatic stone protein, a phosphoprotein which inhibits calcium carbonate precipitation from pancreatic juice. Biochem Biophys Res Commun 1983; 110: 69-74.
15. 15 De Caro A, Multigner L, Dagorn JC, Sarles H. The human pancreatic stone protein. Biochemie 1988; 70: 1209-1214.
16. 16 Katsuzaki T, Tatemichi N, Takeichi C, Hayakawa S, Hayakawa T, Shibata T, et al. Enzyme immunoassay for specific analysis of pancreatic stone protein in human pancreatic juice. J Clin Lab Anal 1992; 6: 375-378.
17. 17 Katsuzaki T, Tatemichi N, Takeichi C, Hayakawa S, Hayakawa T, Shibata T, et al. Enzyme immunoassay and immunochemical characterization of pancreatic stone protein in human serum. J Clin Lab Anal 1992; 6: 143-147.
18. 2-macroglobulin-trypsin complex-like substance (MTLS) in the activation of pancreatic juice. Pancreas 1997; 15: 345-349.
19. 19 Hayakawa T, Kondo T, Shibata T, Kitagawa M, Sakai Y, Sobajima H, et al. Serum pancreatic stone protein in pancreatic diseases. Int J Pancreatol 1993; 13: 97-103.
20. 20 Knaus A, Zimmerman JE, Wargner DP, Draper EA, Lawrence DE. APACHE acute physiology and chronic health evaluation: a severity of disease classification system. Crit Care Med 1984; 12: 975-977.
21. 21 Saito Y, Yamamoto M. Severe acute pancreatitis in Japan, in Acute Pancreatitis: Diagnosis and Therapy, Edward L, Bradley III, eds. Raven, New York 1994; pp. 139-144.
22. 22 Schmiegel WH, Burchert M, Kalthoff H, Thiele HG, Bützow HG, Klose G, et al. Pancreatic stone protein in serum of patients with pancreatitis. Lancet 1986; 2: 686.
23. 23 Wilson C, Heads A, Shenkin A, Imrie CW. C-reactive protein, antiproteases and complement factors as objective markers of severity in acute pancreatitis. Br J Surg 1989; 79: 177-181.